Skip to the page

Data / Form D filings / Cell Microsystems, Inc.

Cell Microsystems, Inc.: Form D filings

Cell Microsystems, Inc., a biotechnology company in Durham, NC, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on August 28, 2023, reports $6.5 million sold of a $13 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
801 CAPITOLA DRIVE, SUITE 10, Durham, NC, 27713
Phone
(252) 285-9842
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1781008

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 28, 2023New notice$13,000,668$6,500,000$6,500,6681Aug 11, 2023sec.gov
Nov 15, 2021New notice$12,666,875$12,666,164$71117Nov 8, 2021sec.gov
Jun 27, 2019New notice$2,200,000$1,850,000$350,00012Jun 12, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rob M. CaponeDirector
Gary M. PaceExecutive Officer, Director
Christopher M. SimsExecutive Officer, Director
Alexander M. HerzickDirector
Deval M. LashkariDirector
Brett M. WilliamsDirector

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Aug 28, 2023 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cell Microsystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.